These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1291742)

  • 21. [The pharmacodynamics of anti-arrhythmia preparations and their different combinations when administered intravenously].
    Abdalla A; Mazur NA; Iavorskaia NV; Kheĭmets GI; Chikovani SI; Potekhin EG
    Ter Arkh; 1992; 64(8):20-5. PubMed ID: 1279828
    [No Abstract]   [Full Text] [Related]  

  • 22. Electrophysiologically guided antiarrhythmic therapy versus beta-blocker therapy in patients with ventricular tachyarrhythmias.
    Vaitkus PT; Capeless MA
    N Engl J Med; 1993 Feb; 328(5):357; author reply 358. PubMed ID: 8093552
    [No Abstract]   [Full Text] [Related]  

  • 23. Reproducibility of drug efficacy predictions by Holter monitoring in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. ESVEM Investigators.
    Reiter MJ; Karagounis LA; Mann DE; Reiffel JA; Hahn E; Hartz V
    Am J Cardiol; 1997 Feb; 79(3):315-22. PubMed ID: 9036751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Definition of predicted effective antiarrhythmic drug therapy for ventricular tachyarrhythmias by the electrophysiologic study approach: randomized comparison of patient response criteria.
    Mitchell LB; Sheldon RS; Gillis AM; Connolly SJ; Duff HJ; Gardner MJ; Hui WK; Ramadan D; Wyse DG
    J Am Coll Cardiol; 1997 Nov; 30(5):1346-53. PubMed ID: 9350938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of antiarrhythmic drug efficacy for ventricular tachyarrhythmias using ambulatory monitoring and electrophysiological techniques.
    Greenspan AM
    Circulation; 1993 Feb; 87(2):643-5. PubMed ID: 8123058
    [No Abstract]   [Full Text] [Related]  

  • 26. Recurrent ventricular tachycardia in a child with juvenile dermatomyositis - an unusual association.
    Jindal G; Singh S; Suri D; Rawat A; Rohit M
    Int J Rheum Dis; 2012 Apr; 15(2):e26-7. PubMed ID: 22462430
    [No Abstract]   [Full Text] [Related]  

  • 27. [Ventricular tachyarrhythmia].
    Harumi K
    Nihon Naika Gakkai Zasshi; 1990 Sep; 79(9):1272-80. PubMed ID: 2258673
    [No Abstract]   [Full Text] [Related]  

  • 28. Wide complex tachycardia and adenosine.
    Schuller JL; Varosy PD; Nguyen DT
    JAMA Intern Med; 2013 Sep; 173(17):1644-6. PubMed ID: 23897223
    [No Abstract]   [Full Text] [Related]  

  • 29. [Problems of medicinal prevention of different forms of paroxysmal tachycardia and tachyarrhythmia].
    Golikov AP; Ustinova EZ
    Ter Arkh; 1976; 48(1):90-3. PubMed ID: 1265689
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on the efficacy and prognostic significance of drug therapy of ventricular tachyarrhythmias.
    Borchard U; Manz M
    Herz; 1997 Jun; 22 Suppl 1():1-2. PubMed ID: 9259190
    [No Abstract]   [Full Text] [Related]  

  • 31. The development of antiarrhythmic drugs.
    Fisher L
    Am Heart J; 2000 Apr; 139(4):S200-1. PubMed ID: 10740132
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharma-clinics. How I treat.... Ventricular tachycardia in children].
    Massin M
    Rev Med Liege; 1996 Feb; 51(2):147-9. PubMed ID: 8650446
    [No Abstract]   [Full Text] [Related]  

  • 33. Propofol as an antiarrhythmic.
    Heams RM
    Br J Anaesth; 2002 Nov; 89(5):798; author reply 799. PubMed ID: 12425306
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of electrical storm--is long term antiarrhythmic therapy indicated?
    Vaidyanathan D; Prabhakar D
    Int J Cardiol; 2000 May; 73(3):297. PubMed ID: 10917765
    [No Abstract]   [Full Text] [Related]  

  • 35. [The efficacy of bonnecor in refractory ventricular tachycardia in a patient with ischemic heart disease].
    Parkhomenko AN; Stepanenko AP; Beziuk NN; Nagnybeda EN; Deiak SI
    Lik Sprava; 1994 Feb; (2):90-2. PubMed ID: 8073734
    [No Abstract]   [Full Text] [Related]  

  • 36. Effectiveness of Deep Sedation for Patients With Intractable Electrical Storm Refractory to Antiarrhythmic Drugs.
    Martins RP; Urien JM; Barbarot N; Rieul G; Sellal JM; Borella L; Clementy N; Bisson A; Guenancia C; Sagnard A; Schumacher S; Gandjbakhch E; Duchateau J; Tixier R; Goepp A; Hamon D; Lellouche N; Champ-Rigot L; Milliez P; Marijon E; Varlet E; Garcia R; Degand B; Bouju P; Mabo P; Leclercq C; Behar N; Pavin D; de Chillou C; Sacher F; Galand V
    Circulation; 2020 Oct; 142(16):1599-1601. PubMed ID: 33074763
    [No Abstract]   [Full Text] [Related]  

  • 37. Beyond adenosine.
    Weinstein E
    JEMS; 2008 Jul; 33(7):22; author reply 22. PubMed ID: 18602580
    [No Abstract]   [Full Text] [Related]  

  • 38. ANTIDYSRHYTHMIC AGENTS. Managing prehospital stable v tach.
    Cortez E; Cash C; Keseg DP; Fowler RL
    JEMS; 2016 Mar; 41(3):48-51. PubMed ID: 27120857
    [No Abstract]   [Full Text] [Related]  

  • 39. [A new synthetic antiarrhythmic drug: bunaftine. Clinical study].
    De' Thomatis M; Puppo N; Oddone G
    Minerva Cardioangiol; 1975 Dec; 23(12):924-31. PubMed ID: 1232588
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical significance of electrophysiologic drug testing in the longterm therapy of class I, III and IV antiarrhythmic drugs for recurrent ventricular tachyarrhythmia].
    Kasanuki H; Ohnishi S; Amamiya K; Umemura J; Shoda M; Hosoda S
    Jpn Circ J; 1992; 56 Suppl 5():1458-61. PubMed ID: 1291742
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.